Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Codrituzumab |
| Trade Name | |
| Synonyms | GC-33|RG 7686|RG7686|RG-7686|RO 5137382|RO5137382 |
| Drug Descriptions |
Codrituzumab (GC-33) is a monoclonal antibody against Glypican-3 (GPC3), which may result in cytotoxicity due to its association with CD16-Fc-gamma RIIIa (PMID: 27085251, PMID: 31510063). |
| DrugClasses | GPC3 Antibody 7 |
| CAS Registry Number | 1365267-33-9 |
| NCIT ID | C80043 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Codrituzumab | Codrituzumab | 0 | 1 |